These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25251920)

  • 1. Management of neuromuscular blockade in ambulatory patients.
    Schreiber JU
    Curr Opin Anaesthesiol; 2014 Dec; 27(6):583-8. PubMed ID: 25251920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting).
    Fuchs-Buder T; Mencke T
    Eur J Anaesthesiol Suppl; 2001; 23():53-9. PubMed ID: 11766248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscle relaxants in ambulatory anesthesia].
    Takeda J
    Masui; 2008 Jul; 57(7):845-52. PubMed ID: 18649639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade.
    Fink H; Hollmann MW
    Minerva Anestesiol; 2012 Apr; 78(4):473-82. PubMed ID: 22454044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular block and current treatment strategies for its reversal in children.
    Meretoja OA
    Paediatr Anaesth; 2010 Jul; 20(7):591-604. PubMed ID: 20642658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual paralysis: a real problem or did we invent a new disease?
    Donati F
    Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to optimize neuromuscular blockade in ambulatory setting?
    Meistelman C; Plaud B; Debaene B
    Curr Opin Anaesthesiol; 2019 Dec; 32(6):714-719. PubMed ID: 31689267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].
    Unterbuchner C; Ehehalt K; Graf B
    Anaesthesist; 2019 Nov; 68(11):744-754. PubMed ID: 31650189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine.
    Llauradó S; Sabaté A; Ferreres E; Camprubí I; Cabrera A
    Rev Esp Anestesiol Reanim; 2014 Dec; 61(10):565-70. PubMed ID: 24411663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
    McLean DJ; Diaz-Gil D; Farhan HN; Ladha KS; Kurth T; Eikermann M
    Anesthesiology; 2015 Jun; 122(6):1201-13. PubMed ID: 25919486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review.
    Tajaate N; Schreiber JU; Fuchs-Buder T; Jelting Y; Kranke P
    Eur J Anaesthesiol; 2018 Mar; 35(3):184-192. PubMed ID: 29189420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac arrest and neuromuscular blockade reversal agents in the transplanted heart.
    Bertolizio G; Yuki K; Odegard K; Collard V; Dinardo J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1374-8. PubMed ID: 23164506
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
    Carron M; Parotto E; Ori C
    Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of neuromuscular blocking agents: current practice.
    Nagelhout JJ
    AANA J; 2013 Dec; Suppl():8-11. PubMed ID: 24592527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.